ALESINI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 452
EU - Europa 128
AS - Asia 57
AF - Africa 9
Totale 646
Nazione #
US - Stati Uniti d'America 449
IT - Italia 64
SE - Svezia 30
CN - Cina 19
IN - India 18
SG - Singapore 18
FI - Finlandia 11
DE - Germania 7
TG - Togo 7
IE - Irlanda 6
PL - Polonia 4
CA - Canada 3
GB - Regno Unito 3
AM - Armenia 1
BG - Bulgaria 1
EG - Egitto 1
FR - Francia 1
IR - Iran 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 646
Città #
Fairfield 75
Chandler 49
Woodbridge 33
Seattle 31
Cambridge 30
Ashburn 29
Houston 28
Wilmington 24
Beijing 13
Ann Arbor 10
Princeton 10
Rome 10
Plano 9
Singapore 9
Dearborn 8
Lawrence 7
Lomé 7
Milan 7
Dublin 6
New York 6
San Paolo di Civitate 6
Boston 5
Des Moines 5
Fremont 5
Redmond 4
San Diego 4
Andover 3
Helsinki 3
Millbury 3
Norwalk 3
Redwood City 2
Rieti 2
Toronto 2
Varedo 2
Berlin 1
Bologna 1
Bolzano 1
Bühl 1
Caivano 1
Casoria 1
Fuzhou 1
Hefei 1
Jinan 1
Las Vegas 1
Levallois-perret 1
Lodz 1
Monterotondo 1
Montréal 1
Muizenberg 1
New Delhi 1
Ningbo 1
Polska 1
Pune 1
Roda 1
San Mateo 1
Sassuolo 1
Simi Valley 1
Sofia 1
Southend 1
Trento 1
Westminster 1
Zhengzhou 1
Totale 478
Nome #
Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy. a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO) 86
Antiangiogenic agents are ineffective to increase complete response rate in MRCC:A meta-analysis 79
Multimodality Treatment of Gynecomastia in Patients Receiving Antiandrogen Therapy for Prostate Cancer in the Era of Abiraterone Acetate and New Antiandrogen Molecules 77
Clinical and Pathological Features of Primary Neuroectodermal Tumor/Ewing Sarcoma of the Kidney 76
Clinical outcomes of castration-resistant prostate cancer treatments administered as third or fourth line following failure of docetaxel and other second-line treatment: results of an Italian multicentre study 76
Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials 70
Medical strategies for treatment of castration resistant prostate cancer (CRPC) docetaxel resistant. 56
Erlotinib and gefitinib for elderly patients with advanced non-small-cell lung cancer. 53
Thyrotoxicosis during sunitinib therapy: a case report. 43
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in ER+/HERr2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 38
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study 17
Totale 671
Categoria #
all - tutte 1.731
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.731


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020167 20 6 1 18 17 22 22 16 15 20 7 3
2020/202144 2 8 1 1 1 7 1 5 7 0 3 8
2021/202290 2 7 12 0 10 2 2 10 3 9 17 16
2022/2023147 19 29 12 7 22 23 1 10 16 1 5 2
2023/202465 5 9 1 2 6 6 2 4 0 10 14 6
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 671